Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome

A high antithymocyte globulin dose increases the risk of relapse after reduced intensity conditioning HSCT with unrelated donors

(2013) Mats Remberger et al.   CLINICAL TRANSPLANTATION

Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes

(2012) C. G. Brunstein et al.   BLOOD

Omission of in vivo T-cell depletion promotes rapid expansion of naïve CD4+ cord blood lymphocytes and restores adaptive immunity within 2 months after unrelated cord blood transplant

(2012) Robert Chiesa et al.   BRITISH JOURNAL OF HAEMATOLOGY

Paediatric Reference Values for the Peripheral T cell Compartment

(2012) E. J. H. Schatorjé et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Effects of different serum-levels of ATG after unrelated donor umbilical cord blood transplantation

(2012) Mats Remberger et al.   TRANSPLANT IMMUNOLOGY

Serious Infection Risk and Immune Recovery after Double-Unit Cord Blood Transplantation Without Antithymocyte Globulin

(2011) Craig Sauter et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Immune Reconstitution after Double Umbilical Cord Blood Stem Cell Transplantation: Comparison with Unrelated Peripheral Blood Stem Cell Transplantation

(2011) Caron A. Jacobson et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

CMV Infection after Transplant from Cord Blood Compared to Other Alternative Donors: The Importance of Donor-Negative CMV Serostatus

(2011) Małgorzata Mikulska et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Novel treatment concepts for graft-versus-host disease

(2011) D. Wolf et al.   BLOOD

Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients

(2011) F. Milano et al.   BLOOD

IgG antibodies to ATG early after pediatric hematopoietic SCT increase the risk of acute GVHD

(2011) C M Jol-van der Zijde et al.   BONE MARROW TRANSPLANTATION

Pre-emptive rituximab based on viraemia and T cell reconstitution: a highly effective strategy for the prevention of Epstein-Barr virus-associated lymphoproliferative disease following stem cell transplantation

(2011) Austen Worth et al.   BRITISH JOURNAL OF HAEMATOLOGY

Outcomes, infections, and immune reconstitution after double cord blood transplantation in patients with high-risk hematological diseases

(2011) A. Ruggeri et al.   Transplant Infectious Disease

Double cord blood transplantation: extending the use of unrelated umbilical cord blood cells for patients with hematological diseases

(2010) Vanderson Rocha et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood

(2010) C. G. Brunstein et al.   BLOOD

How I treat adenovirus in hematopoietic stem cell transplant recipients

(2010) C. A. Lindemans et al.   BLOOD

Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units

(2009) M. R. Verneris et al.   BLOOD

Human herpes virus 6 infection is a hallmark of cord blood transplant in adults and may participate to delayed engraftment: a comparison with matched unrelated donors as stem cell source

(2009) P Chevallier et al.   BONE MARROW TRANSPLANTATION

KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia

(2009) R Willemze et al.   LEUKEMIA

Unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients: A meta-analysis

(2009) Jing Wang et al.   LEUKEMIA RESEARCH

Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors

(2008) M. L. MacMillan et al.   BLOOD